Cidara Therapeutics, Inc. (DELISTED) (CDTX:DL)
221.38
0.00 (0.00%)
USD |
NASDAQ |
Feb 25, 16:00
Cidara Therapeutics Free Cash Flow : -132.94M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 12.36B |
| Cogent Biosciences, Inc. | -266.00M |
| Olema Pharmaceuticals, Inc. | -134.67M |
| Rhythm Pharmaceuticals, Inc. | -149.13M |
| BridgeBio Pharma, Inc. | -455.50M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -40.62M |
| Cash from Investing (Quarterly) | -176.47M |
| Cash from Financing (Quarterly) | 0.16M |
| Free Cash Flow Per Share (Quarterly) | -1.511 |
| Free Cash Flow to Equity (Quarterly) | -40.27M |
| Free Cash Flow to Firm (Quarterly) | -40.62M |
| Free Cash Flow Yield | -3.62% |